We are live on ! Find out more
PBPIA

Pivotal bioVenture Partners Investment Advisor Portfolio holdings

AUM $280M
1-Year Est. Return 181.4%
This Fund
S&P 500
This Quarter Est. Return
+1.27%
1 Year Est. Return
+181.4%
3 Year Est. Return
+730.97%
5 Year Est. Return
+1,157.4%
10 Year Est. Return
–
AUM
$230M
AUM Growth
-$43.7M
Cap. Flow
-$14.4M
Cap. Flow %
-6.26%
Top 10 Hldgs %
100%
Holding
11
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
RLYB icon
Rallybio
RLYB
+$984K

Top Sells

Rank Stock Value
1
AKUS
Akouos Inc
AKUS
+$12.1M
2
PCVX icon
Vaxcyte
PCVX
+$3.26M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$150M 65.45%
765,895
– –
PCVX icon
2
Vaxcyte
PCVX
$8.81B
$33.2M 14.45%
693,039
-83,000
-11% -$3.26M
RLYB icon
3
Rallybio
RLYB
$87M
$15.8M 6.87%
300,581
+16,667
+6% +$984K
ARQT icon
4
Arcutis Biotherapeutics
ARQT
$3.3B
$8.42M 3.66%
569,041
– –
VIGL
5
DELISTED
Vigil Neuroscience
VIGL
$7.01M 3.05%
560,595
– –
FUSN
6
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$4.92M 2.14%
1,560,984
– –
EXAI
7
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$4.12M 1.79%
772,285
– –
INZY
8
DELISTED
Inozyme Pharma
INZY
$2.79M 1.22%
2,661,154
– –
BOLT icon
9
Bolt Biotherapeutics
BOLT
$7.65M
$2.46M 1.07%
94,573
– –
ALGS icon
10
Aligos Therapeutics
ALGS
$45.5M
$708K 0.31%
29,729
– –
AKUS
11
DELISTED
Akouos Inc
AKUS
– –
-1,794,088
Closed -$12.1M

Similar funds

HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
CCC
Compass Capital Corp Braintree, Massachusetts $279M AUM 28.36% 1-Year Est. Return
PHC
Panoramic Hills Capital Road Town $280M AUM
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return

Pivotal bioVenture Partners Investment Advisor's Q4 2022 Portfolio in Review

As of Q4 2022, Pivotal bioVenture Partners Investment Advisor held 11 positions worth $230M, down 16% from $274M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Pivotal bioVenture Partners Investment Advisor withdrew a net $14.4M in Q4 2022, closing 1 position and reducing 1 holding. Its most notable exit was Akouos Inc, an estimated $12.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Pivotal bioVenture Partners Investment Advisor added an estimated $984K to Rallybio.

  • Pivotal bioVenture Partners Investment Advisor added most to Rallybio in Q4 2022, an estimated $984K increase.
  • Pivotal bioVenture Partners Investment Advisor's biggest Q4 2022 reduction was Vaxcyte, cutting an estimated $3.26M.
  • Pivotal bioVenture Partners Investment Advisor fully exited Akouos Inc in Q4 2022, selling an estimated $12.1M.
  • Pivotal bioVenture Partners Investment Advisor's ten largest holdings make up 100% of its $230M portfolio in Q4 2022.
  • Pivotal bioVenture Partners Investment Advisor opened 0 new positions and closed 1 in Q4 2022.
  • Pivotal bioVenture Partners Investment Advisor's portfolio value fell 16% quarter-over-quarter to $230M.

Based on Pivotal bioVenture Partners Investment Advisor's 13F filing for Q4 2022, filed 13 Feb 2023.